Filed: 11/14/2022ACC: 0001507673-22-000019
📋 What this filing means
RP MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $216.4K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$216.4K
Total AUM (reported)
4.96M
Total Shares
Allocation by class
COM$216.4K100.0%
Portfolio Concentration
Top 3$216.4K100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 4.96M
Sole
Full voting authority
4.96M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other3
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
BIOHAVEN PHARMACTL HLDG CO L
DFNDShares1.11M
TypeSH
Market value$168.0K
77.60%
Sole
1.11M
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
DFNDShares3.85M
TypeSH
Market value$48.5K
22.39%
Sole
3.85M
Shared
0.00
None
0.00
VIRACTA THERAPEUTICS INC
DFNDShares3.70K
TypeSH
Market value$16.00
<0.01%
Sole
3.70K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIOHAVEN PHARMACTL HLDG CO LDFND | COM | 1.11M | SH | $168.0K 77.60% | 1.11M | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCDFND | COM | 3.85M | SH | $48.5K 22.39% | 3.85M | 0.00 | 0.00 |
VIRACTA THERAPEUTICS INCDFND | COM | 3.70K | SH | $16.00 <0.01% | 3.70K | 0.00 | 0.00 |